Get the Weekly Intelligence Brief — top committee picks every Sunday.
AVTR · NASDAQ · STOCK

Avantor

Healthcare Updated August 08, 2026
$13.59
52W $7.26 – $15.93
64/100
$9.19B
-16.2
0.94
AI Committee Verdict
Buy
64/100
Conviction: Contested · 80% agreement · 5 analysts
+6.1%
-13.0%
0.47:1
Contested
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.

Is AVTR Bullish or Bearish?

Bullish. Innellis AI committee rates Avantor (AVTR) Buy with a composite score of 64/100 , based on 5 analysts with 80% agreement. Last updated August 08, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +10.53 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -9.47 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — quarter-over-quarter growth rate is accelerating, not just positive. Risk Analyst remains cautious — bollinger bandwidth of 42.6% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
  • News sentiment is positive (+0.20 across 32 articles, 14d) — News
Bear Case
  • Weekly RSI at 87 -- overbought on the larger timeframe too — Technical
  • Bollinger bandwidth of 42.6% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 08, 2026
Overall Committee Score
64/100
Agreement
80%
Analysts
5
Conviction
Contested
Sector Rank
Top 21%
of 95 Healthcare peers
Growth Analyst bullish
85 / 100 · Low confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst bullish
68 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− Weekly RSI at 87 -- overbought on the larger timeframe too
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 42.6% signals elevated volatility
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
64 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 32 articles, 14d)
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 4 existing position pair(s) are highly correlated already
Open Full Terminal →

Investment Thesis Evolution

Committee score strengthened from 57.0 to 64.5.

Analyst-level changes:
  • Growth Analyst: stance neutral->bullish; score 50->85 (+35).
  • News Analyst: +1 bullish signal(s).
  • Risk Analyst: +1 bearish signal(s).
  • Technical Analyst: +1 bearish signal(s).
  • Value Analyst abstained (was neutral at 55).

Comparing 2026-08-07 to 2026-08-08 (1 day apart).

Technical Analysis

RSI (14)
67.1
Neutral
MACD Histogram
0.061
Bullish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Hh Hl
Support
$11.82
Resistance
$14.42
Bollinger %B
0.76
Inside Bands
Price vs Moving Averages
EMA 9
$13.21 Above
EMA 21
$12.35 Above
EMA 50
$11.07 Above
EMA 200
$10.74 Above

Fundamental Analysis

Valuation
99
Growth
57
Profitability
7
Financial Health
91
Cash Flow
70
Valuation
P/E Ratio -16.2×
P/B Ratio 1.63×
PEG Ratio 0.32
Dividend Yield 0.00%
52W High $15.93
52W Low $7.26
Quality & Growth
ROE -952.7%
ROA -449.5%
Gross Margin 3182.6%
Operating Margin -435.3%
Revenue Growth YoY
Debt / Equity 0.01
AI Fundamental Assessment
P/E ratio of -16.2 (inexpensive relative to a 15-40x range); Price-to-book of 1.6x; PEG ratio of 0.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -9.5%; Return on assets of -4.5%; Net margin of -8.8%; Gross margin of 31.8%; Current ratio of 1.78 (healthy short-term liquidity); Debt-to-equity of 0.01; Free cash flow per share is positive (0.67); Most recent quarter beat estimates by 8.6%; 2 consecutive earnings beats; EPS growth accelerating (-22.7% -> +23.5% QoQ); Average YoY EPS growth of -12.5%; Analyst estimates falling over recent quarters
Get the Full AVTR Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore AVTR Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime